Novartis AG EPS - Earnings per Share 2010-2024 | NVS

Novartis AG earnings per share (EPS) for the twelve months ending September 30, 2024 was $8.53, a 128.69% increase year-over-year.

  • Novartis AG EPS for the quarter ending September 30, 2024 was $1.57, a 84.71% increase year-over-year.
  • Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.
  • Novartis AG 2022 annual EPS was $3.17, a 70.18% decline from 2021.
  • Novartis AG 2021 annual EPS was $10.63, a 201.99% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Novartis AG EPS - Earnings per Share 2010-2024 | NVS

  • Novartis AG EPS for the quarter ending September 30, 2024 was $1.57, a 84.71% increase year-over-year.
  • Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.
  • Novartis AG 2022 annual EPS was $3.17, a 70.18% decline from 2021.
  • Novartis AG 2021 annual EPS was $10.63, a 201.99% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.